Literature DB >> 14752802

Non-conventional therapies in childhood cancer: guidelines for distinguishing non-harmful from harmful therapies: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology.

Momcilo Jankovic1, John J Spinetta, Antonio Gentil Martins, Andrea Pession, Michael Sullivan, Giulio J D'Angio, Tim Eden, Myriam Weyl Ben Arush, Sutaryo X, Leena-Riitta Punkko, Claudia Epelman, Giuseppe Masera.   

Abstract

This is the 11th official document of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology, instituted in 1991. There is a tendency for some physicians to make blanket statements against the use of non-proven, non-conventional therapies, even when these therapies are not harmful. There is an equal and opposite tendency on the part of many parents to do all that they possibly can for their children, including using any non-conventional therapy they feel might do some good. The health care team must open a healthy dialogue with parents that will lead to a clear distinction between those complementary therapies that are harmful and those that are not, indeed, might even be helpful psychologically if not therapeutically. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14752802     DOI: 10.1002/pbc.10418

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Use of complementary and alternative medicine by patients presenting to a Paediatric Emergency Department.

Authors:  Tycho Jan Zuzak; Isabelle Zuzak-Siegrist; Ana Paula Simões-Wüst; Lukas Rist; Georg Staubli
Journal:  Eur J Pediatr       Date:  2008-07-03       Impact factor: 3.183

2.  Complementary and alternative medicines for use in supportive care in pediatric cancer.

Authors:  Kara M Kelly
Journal:  Support Care Cancer       Date:  2006-10-12       Impact factor: 3.359

3.  Genetic variants in MUC4 gene are associated with lung cancer risk in a Chinese population.

Authors:  Zili Zhang; Jian Wang; Jianxing He; Zeguang Zheng; Xiansheng Zeng; Chenting Zhang; Jinmei Ye; Yajie Zhang; Nanshan Zhong; Wenju Lu
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.